E!114244, Blue4Therapy, AcouSort
|Coordinator||AcouSort AB - AcouSort AB Medicon Village|
|Funding from Vinnova||SEK 3 108 500|
|Project duration||September 2020 - April 2023|
Purpose and goal
The project aims to develop a new platform - BlueSORT - to enable the use of Blue Cells as stem cell therapy to treat chronic conditions that currently lack efficient treatment. The idea is that BlueSORT will enable a safe and cost-effective preparation of stem cells for regenerative treatment in a patient-centered (PoC) environment. The main project result will be a standardized beta version of a PoC platform for Blue Cell-anrikning and a commercial version of the enzymatic solution for efficient Blue Cell-extraktion.
Expected results and effects
During the project, the consortium intends to develop a platform with the capacity to enrich Blue Cells from lipoaspirate and thus be able to offer a PoC stem cell treatment of chronic conditions and thereby increase treatment efficiency. The project result will be a standardized beta version of a PoC platform for Blue Cell-enrichment and a commercial version of the enzymatic solution for efficient Blue Cell-extraktion. The platform will be delivered with training materials and documentation required for third parties to be able to operate
Planned approach and implementation
AcouSort´s part in Blue 4 Therapy aims to develop a separation method based on the company´s acoustic separation technology. With the help of acoustics, Blue-Cells will be separated out and concentrated from other cells found in lipoaspirate. AcouSort also intends to work during the project with the development of a module containing the company´s technology and that is specially adapted for the purification of bluecells and which is adapted for single use or sterilization. Initially, AcouSort will work with application development for the separation method of blue cells.